Company

LIPELLA PHARMACEUTICALS INC. (LIPO)

Standardized SEC financial data for LIPELLA PHARMACEUTICALS INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001347242 · OTC · Pharmaceutical Preparations.

Revenue growth (YoY)

19.3%

Return on equity

-261.3%

Free cash flow

-$4.0M

Current ratio

3.47×

EPS (diluted)

$-4.79

Ratios for fiscal year 2024, standardized from SEC filings.

Income statement

USD	FY2021	FY2022	FY2023	FY2024
Revenue	$259K	$184K	$450K	$536K
R&D expense	$1.5M	$2.5M	$3.0M	$3.6M
SG&A expense	$718K	$226K	$2.2M	$2.0M
Operating income	-$1.9M	-$2.6M	-$4.7M	-$5.1M
EBITDA	—	—	-$4.7M

Standardized from LIPELLA PHARMACEUTICALS INC.'s SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024
Cash & equivalents	$607K	$1.4M	$5.1M	$3.3M	$2.2M
Total current assets	—	$1.8M	$5.8M	$3.4M	$2.6M
Property, plant & equipment	—	—	—	$13K	$10K
Total assets

Cash flow

USD	FY2021	FY2022	FY2023	FY2024
Operating cash flow	-$989K	-$1.8M	-$3.2M	-$4.0M
Capital expenditures	—	—	$14K	—
Free cash flow	—	—	-$3.2M	—
Investing cash flow	-$301K	$301K	-$14K	—

Get LIPO data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/LIPO/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/LIPO/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View LIPO filings on SEC EDGAR →